Arimidex vs Aromasin: Which AI Actually Fits Your Cycle?
Arimidex and Aromasin both block estrogen production but through fundamentally different mechanisms. That difference determines dosing frequency, what happens when you stop taking them, how forgiving they are when you overshoot, and which one is safer for your lipid profile. Choosing the right one is not about preference - it is about understanding the pharmacology.
The Core Difference: Reversible vs Suicidal Inhibition
This is the most important concept and the one most articles fail to explain clearly. Both drugs block aromatase - the enzyme that converts testosterone into estradiol. But they block it in completely different ways.
- Competes with testosterone for aromatase binding
- Reversible - aromatase recovers when drug clears
- Half-life 41-48 hours - requires consistent daily dosing
- Estrogen rebounds 48-72h after stopping
- Precise dial - dose up or down quickly
- Non-steroidal structure
- Permanently deactivates aromatase enzyme
- Irreversible - enzyme destroyed, not just blocked
- Half-life 27 hours but effect outlasts plasma levels
- No estrogen rebound after stopping
- Less precise - cannot quickly reverse over-suppression
- Steroidal structure - mild androgenic activity
Full Comparison: Every Practical Difference
| Property | Arimidex (Anastrozole) | Aromasin (Exemestane) |
|---|---|---|
| Inhibition type | Reversible competitive | Irreversible suicidal More permanent |
| Half-life | 41-48 hours | 27 hours |
| Steady state | 7 days | 7 days Equal |
| Estrogen suppression | ~80% | ~85% Slightly stronger |
| Estrogen rebound on stop | Yes - within 48-72h | No - enzyme must be resynthesized Safer stop |
| HDL cholesterol impact | Neutral to negative | Neutral to slight improvement Better for lipids |
| Androgenic activity | None - non-steroidal | Mild - steroidal structure supports libido Better mood |
| Dosing flexibility | Easy to adjust up or down More precise | Less flexible - permanent enzyme deactivation |
| Tamoxifen compatibility | Avoid - reduces Nolvadex efficacy | Compatible with SERMs PCT friendly |
| IGF-1 effect | Neutral | Slight increase in IGF-1 Anabolic bonus |
Typical Dosing Protocols
Crashing Estrogen: The Most Common AI Mistake
Both compounds can crash estrogen if overdosed. Low estrogen is not a training advantage - it is a performance killer.
| Symptom | High E2 | Crashed E2 (Over-AI) |
|---|---|---|
| Joints | Puffy, swollen | Dry, painful, creaky |
| Mood | Emotional, irritable | Flat, depressed, no motivation |
| Libido | Can be elevated | Crashed - worse than high E2 |
| Training pumps | Water-driven bloat | Pumps disappear completely |
| Recovery | Watery weight gain | Poor - estrogen supports muscle repair |
| Recovery after stopping AI | Arimidex: rebound 48-72h | Aromasin: slower, no spike | |
Which to Choose
| Your Situation | Better Choice | Reason |
|---|---|---|
| First AI use - dialling in | Arimidex More controllable | Easier to adjust dose up or down quickly |
| PCT with Nolvadex or Clomid | Aromasin No interaction | Arimidex reduces SERM efficacy - clinically documented |
| Concerned about lipids | Aromasin Better HDL | Neutral to slight HDL improvement vs neutral/negative Arimidex |
| Libido and mood priority | Aromasin Mild androgen | Steroidal structure provides mild androgenic support |
| Stopping AI during cycle | Aromasin No rebound | No estrogen spike on discontinuation |
| High aromatizing cycle | Aromasin Slightly stronger | 85% vs 80% suppression - meaningful at high doses |
| Sensitive to over-suppression | Arimidex Faster reversal | Stop drug and E2 rebounds quickly - easier to correct |
For additional AI comparisons see Arimidex vs Femara. For full estrogen management strategy see estrogen control on cycle.
Bottom Line
- Arimidex half-life 41-48h (reversible) vs Aromasin 27h (irreversible) - but Aromasin effect outlasts its plasma levels
- Aromasin suppresses estrogen 85% vs Arimidex 80% - meaningful difference at high testosterone doses
- Stopping Arimidex causes estrogen rebound in 48-72h - stopping Aromasin causes no rebound
- Aromasin improves or maintains HDL - Arimidex is neutral to negative on cholesterol
- Aromasin has mild androgenic activity - supports libido and mood better than Arimidex
- Never combine Arimidex with Tamoxifen - reduces efficacy of both - use Aromasin in PCT
- Target E2 20-40 pg/mL on cycle - bloodwork not symptoms alone should guide dosing